Lei Fu Selected Research

Cycloleucine

1/2022

METTL3 inhibition ameliorates liver damage in mouse with hepatitis B virus-associated acute-on-chronic liver failure by regulating miR-146a-5p maturation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lei Fu Research Topics

Disease

34	Neoplasms (Cancer) 10/2022 - 01/2009
17	Infections 10/2022 - 04/2014
14	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 03/2022 - 09/2010
10	Tuberculosis (Tuberculoses) 01/2022 - 11/2011
7	Inflammation (Inflammations) 04/2022 - 01/2015
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 06/2016
5	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2010
5	Obesity 02/2020 - 01/2016
4	Hypertension (High Blood Pressure) 10/2022 - 03/2021
4	Stomach Neoplasms (Stomach Cancer) 02/2022 - 08/2018
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2021
4	Carcinogenesis 01/2021 - 01/2018
4	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2013
4	Type 2 Diabetes Mellitus (MODY) 12/2019 - 10/2014
4	Septic Shock (Toxic Shock Syndrome) 01/2019 - 01/2015
3	Acute-On-Chronic Liver Failure 02/2022 - 04/2018
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 09/2016
3	Wounds and Injuries (Trauma) 12/2021 - 06/2019
3	Hypoxia (Hypoxemia) 10/2021 - 05/2008
3	Necrosis 01/2021 - 08/2018
3	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2017
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 12/2012
3	Chronic Hepatitis B 09/2019 - 05/2018
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2018 - 10/2014
3	Brain Neoplasms (Brain Tumor) 01/2018 - 10/2014
2	Acute Kidney Injury (Acute Renal Failure) 03/2022 - 07/2021
2	Neuroinflammatory Diseases 01/2022 - 01/2021
2	Adenocarcinoma of Lung 01/2022 - 09/2019
2	Heart Failure 01/2022 - 01/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021 - 01/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 01/2018
2	Sepsis (Septicemia) 07/2021 - 01/2017
2	Ischemic Stroke 01/2021 - 10/2014
2	Leukemia 01/2021 - 10/2009
2	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 10/2014
2	Circulating Neoplastic Cells 12/2018 - 10/2014
2	Colonic Neoplasms (Colon Cancer) 08/2010 - 01/2009
1	Hydrocephalus (Hydrocephaly) 10/2022

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 09/2022 - 11/2011
10	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2012
10	Proteins (Proteins, Gene)FDA Link 10/2021 - 05/2007
8	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
8	Clofazimine (Lamprene)FDA Link 01/2021 - 09/2009
7	Biological ProductsIBA 10/2022 - 01/2014
7	Messenger RNA (mRNA)IBA 01/2022 - 05/2008
5	DNA (Deoxyribonucleic Acid)IBA 09/2016 - 01/2009
4	CytokinesIBA 04/2022 - 01/2015
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2018
4	AerosolsIBA 01/2022 - 01/2019
4	LigandsIBA 01/2021 - 01/2010
4	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2020
4	Linezolid (Zyvox)FDA Link 10/2020 - 02/2014
4	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 10/2014
4	Insulin (Novolin)FDA Link 01/2020 - 10/2014
3	Circular RNAIBA 01/2022 - 01/2020
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 08/2018
3	Long Noncoding RNAIBA 01/2021 - 01/2018
2	CreatinineIBA 08/2022 - 03/2021
2	Caspase 1 (ICE Protease)IBA 04/2022 - 01/2021
2	Photosensitizing Agents (Photosensitizers)IBA 03/2022 - 08/2018
2	GoldIBA 02/2022 - 09/2016
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 11/2016
2	Contrast MediaIBA 01/2022 - 09/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2015
2	ChemokinesIBA 12/2021 - 01/2021
2	Uric Acid (Urate)IBA 12/2021 - 03/2021
2	Estrogen ReceptorsIBA 01/2021 - 12/2012
2	Carcinoembryonic AntigenIBA 01/2021 - 01/2018
2	InflammasomesIBA 01/2021 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2015
2	AntigensIBA 03/2020 - 01/2017
2	Therapeutic UsesIBA 03/2020 - 01/2020
2	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 11/2019 - 02/2019
2	Hepatitis B e AntigensIBA 09/2019 - 08/2016
2	cupric sulfide (CuS)IBA 07/2019 - 09/2016
2	Indicators and Reagents (Reagents)IBA 02/2019 - 08/2018
2	PlatinumIBA 02/2019 - 10/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2014
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2018 - 01/2013
2	Polysaccharides (Glycans)IBA 01/2018 - 06/2017
2	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2018 - 01/2017
2	Isoniazid (Ftivazide)FDA LinkGeneric 11/2016 - 09/2009
2	GraphiteIBA 09/2016 - 04/2016
2	Small Interfering RNA (siRNA)IBA 09/2016 - 01/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 01/2010
2	Estrogens (Estrogen)FDA Link 12/2012 - 08/2010

Therapy/Procedure

19	Therapeutics 09/2022 - 01/2009
6	Drug Therapy (Chemotherapy) 01/2022 - 07/2009
3	Radiotherapy 01/2019 - 11/2017
2	Renal Replacement Therapy (Therapies, Renal Replacement) 03/2022 - 07/2021
2	Liver Transplantation 02/2022 - 10/2021
2	Renal Dialysis (Hemodialysis) 01/2022 - 01/2022
2	Kidney Transplantation 10/2021 - 09/2015
2	Artificial Respiration (Mechanical Ventilation) 07/2021 - 03/2021
2	Chemoradiotherapy 06/2019 - 10/2014
2	Cranial Irradiation 01/2018 - 10/2014
1	Decompressive Craniectomy 10/2022
1	Ventriculoperitoneal Shunt 10/2022